Subscribe to RSS
DOI: 10.1055/s-0030-1259909
Solvent-Free Reaction between Anthranilic Acids and Isocyanides: A Novel Approach for the Synthesis of 2-Unsubstituted 4(3H)-Quinazolinones
Publication History
Publication Date:
15 March 2011 (online)

Abstract
A novel synthesis of 2-unsubstituted 4(3H)-quinazolinones is described. Heating a mixture of an anthranilic acid and an isocyanide under solvent-free conditions afforded the title compounds in good to excellent yields.
Key words
anthranilic acids - isocyanides - 2-unsubstituted 4(3H)-quinazolinones - solvent-free synthesis - cyclizations - heterocycles
-
1a
Rewcastle GW. In Comprehensive Heterocyclic Chemistry III Vol. 8:Katritzky AR.Ramsden CA.Scriven EFV.Taylor RJK. Elsevier Science; Oxford: 2008. Chapt. 2. p.117-252 -
1b
Undheim K.Benneche T. In Comprehensive Heterocyclic Chemistry II Vol. 6:Katritzky AR.Rees CW.Scriven EVF. Pergamon Press; London: 1996. Chapt. 2. p.93-231 - 2
Armarego WLF. Fused Pyrimidines, Part 1: Quinazolines Interscience; New York: 1967. - 3
Cao S.-L.Feng Y.-P.Jiang Y.-Y.Liu S.-Y.Ding G.-Y.Li R.-T. Bioorg. Med. Chem. Lett. 2005, 15: 1915 - 4
Kenichi O.Yoshihisa Y.Toyonari O.Toru I.Yoshio I. J. Med. Chem. 1985, 28: 568 - 5
Wolfe JF.Rathman TL.Sleevi MC.Campbell JA.Greenwood TD. J. Med. Chem. 1990, 33: 161 - 6
Tereshima K.Shimamura H.Kawase A.Tanaka Y.Tanimura T.Kamisaki T.Ishizuka Y.Sato M. Chem. Pharm. Bull. 1995, 43: 2021 - 7
Kurogi Y.Inoue Y.Tsutsumi K.Nakamura S.Nagao K.Yohsitsugu H.Tsuda Y. J. Med. Chem. 1996, 39: 1433 - 8
Kuneš J.Ba˛ant J.Pour M.Waisser K.Šlosárek M.Janota J. Farmaco 2000, 55: 725 -
9a
Jang CS.Fu FY.Wang CY.Huang KC.Lu G.Thou TC. Science 1946, 103: 59 -
9b
Koepfli JB.Mead JF.Brockman JA. J. Am. Chem. Soc. 1947, 69: 1837 - 10
Kobayashi S.Ueno M.Suzuki R.Ishitani H. Tetrahedron Lett. 1999, 40: 2175 -
11a
Bridges AJ. Chem. Rev. 2001, 101: 2541 -
11b
Rewcastle GW.Denny WA.Showalter HDH. Curr. Org. Chem. 2000, 4: 679 -
11c
Bridges AJ. Curr. Med. Chem. 1999, 6: 825 - 12
Niementowski SV. J. Prakt. Chem. 1895, 51: 564 -
13a
Ballard P.Bradbury RH.Harris CS.Hennequin LFA.Hickinson M.Johnson PD.Kettle JG.Klinowska T.Leach AG.Morgentin R.Pass M.Ogilvie DJ.Olivier A.Warin N.Williams EJ. Bioorg. Med. Chem. Lett. 2006, 16: 1633 -
13b
Gomtsyan A.Bayburt EK.Schmidt RG.Zheng GZ.Perner RJ.Didomenico S.Koenig JR.Turner S.Jinkerson T.Drizin I.Hannick SM.Macri BS.McDonald HA.Honore P.Wismer CT.Marsh KC.Wetter J.Stewart KD.Oie T.Jarvis MF.Surowy CS.Faltynek CR.Lee CH. J. Med. Chem. 2005, 48: 744 -
13c
Rocco SA.Barbarini JE.Rittner R. Synthesis 2004, 429 -
14a
Alexandre FR.Berecibar A.Wrigglesworth R.Besson T. Tetrahedron Lett. 2003, 44: 4455 -
14b
Alexandre FR.Berecibar A.Besson T. Tetrahedron Lett. 2002, 43: 3911 - 15
Majo VJ.Perumal PT. Tetrahedron Lett. 1996, 37: 5015 - 16
Kamal A.Reddy KS.Prasad BR.Babu AH.Ramana AV. Tetrahedron Lett. 2004, 45: 6517 - 17
Narasimhulu M.Mahesh KC.Reddy TS.Rajesh K.Venkateswarlu Y. Tetrahedron Lett. 2006, 47: 4381 - 18
Khosropour AR.Mohammadpoor-Baltork I.Ghorbankhani H. Tetrahedron Lett. 2006, 47: 3561 - 19
Chari MA.Shobha D.Mukkanti K. Catal. Commun. 2006, 7: 787 -
20a
Shaabani A.Soleimani E.Rezayan AH. Tetrahedron Lett. 2007, 48: 6137 -
20b
Stockdill JL.Wu X.Danishefsky SJ. Tetrahedron Lett. 2009, 50: 5152 - 21
Shaabani A.Rezayan AH.Sarvary A.Keshipour S.Khavasi HR. Tetrahedron Lett. 2010, 51: 4091 - 22
Wu X.Li X.Danishefsky SJ. Tetrahedron Lett. 2009, 50: 1523 - 23
Basso A.Banfi L.Galatini A.Guanti G.Rastrelli F.Riva R. Org. Lett. 2009, 11: 4068 -
24a
Li X.Yuan Y.Berkowitz WF.Todaro LJ.Danishefsky SJ. J. Am. Chem. Soc. 2008, 130: 13222 -
24b
Hou JL.Ajami D.Rebek J. J. Am. Chem. Soc. 2008, 130: 7810 -
24c
Restorp P.Rebek J. J. Am. Chem. Soc. 2008, 130: 11850 - 25
Marmet D.Boullanger P.Descotes G. Tetrahedron Lett. 1980, 21: 1459 -
26a
Adib M.Ansari S.Feizi S.Bijanzadeh HR. Synlett 2010, 921 -
26b
Adib M.Ansari S.Fatemi S.Bijanzadeh HR.Zhu LG. Tetrahedron 2010, 66: 2723 -
26c
Adib M.Ansari S.Feizi S.Asgarian Damavandi J.Mirzaei P. Synlett 2009, 3263 -
26d
Adib M.Mahdavi M.Ansari S.Malihi F.Zhu LG.Bijanzadeh HR. Tetrahedron Lett. 2009, 50: 7246 -
26e
Adib M.Sheibani E.Bijanzadeh HR.Zhu LG. Tetrahedron 2008, 64: 10681 -
26f
Adib M.Sayahi MH.Ziyadi H.Zhu LG.Bijanzadeh HR. Synthesis 2008, 3289 -
26g
Adib M.Mohammadi B.Bijanzadeh HR. Synlett 2008, 3180 -
26h
Adib M.Mohammadi B.Bijanzadeh HR. Synlett 2008, 177 -
26i
Adib M.Sayahi MH.Ziyadi H.Bijanzadeh HR.Zhu LG. Tetrahedron 2007, 63: 11135 - 27
Adib M.Ansari S.Mohammadi A.Bijanzadeh HR. Tetrahedron Lett. 2010, 51: 30 -
29a
Dömling A. Chem. Rev. 2006, 106: 17 -
29b
Dömling A.Ugi I. Angew. Chem. Int. Ed. 2000, 39: 3169 -
29c
Ugi I. Isonitrile Chemistry Academic Press; London: 1971. -
29d
Walborsky HM.Periasamy MP. In The Chemistry of Functional Groups Suppl. C:Patai S.Rappaport Z. Wiley; New York: 1983. Chapt. 20. p.835-837
References and Notes
General Procedure
for the Preparation of Compounds 3a-l
A
mixture of the appropriate anthranilic acid (2 mmol) and isocyanide
(2.2 mmol) was stirred at 150 ˚C for 2 h. Progress of
the reaction was indicated by TLC monitoring. Next, the reaction
mixture was cooled to r.t. and acetone (2 mL) was added, and stirring
was continued for 10 min at ambient temperature. The precipitate
was filtered and washed with cold acetone (2 mL), and the product
was recrystallized from n-hexane-EtOAc
(1:1). Compounds 3a-i were purified by this procedure, and
compounds 3j-l were
purified by column chromatography using n-hexane-EtOAc
(3:1) as eluent.
3-Cyclohexyl-4(3
H
)-quinazolinone
(3a)
Yield 0.41g (90%); colorless crystals;
mp 126-127 ˚C. IR (KBr): 1659 (C=O),
1596, 1564, 1468, 1399, 1334, 1240, 1172, 1132, 1024, 956, 894,
805, 766, 695 cm-¹. ¹H
NMR (300.1 MHz, CDCl3): δ = 1.20-2.04 [m,
10 H, CH(CH
2)5], 4.77-4.86 [m,
1 H, CH(CH2)5],
7.49 (dd, J = 7.2,
7.4 Hz, 1 H, CH), 7.68 (d, J = 7.6
Hz, 1 H, CH), 7.74 (dd, J = 7.0,
7.9 Hz, 1 H, CH), 8.12 (s, 1 H, CH), 8.31 (d, J = 8.0
Hz, 1 H, CH). ¹³C NMR (75.5 MHz, CDCl3): δ = 25.27,
25.89 and 32.60 (3 × CH2), 53.54 (NCH), 121.93
(C), 126.95, 127.10, 127.24, 134.10 and 143.91 (5 × CH),
147.50 (C), 160.70 (C=O). MS (EI): m/z (%) = 228
(24) [M+], 192 (7), 181 (5), 171
(4), 160 (7), 147 (100), 129 (8), 118 (10), 102 (5), 90 (7), 77
(9), 67 (14), 55 (16), 41 (22). Anal. Calcd for C14H16N2O (228.29):
C, 73.66; H, 7.06; N, 12.27. Found: C, 73.6; H, 7.2; N, 12.1.
6-Chloro-3-cyclohexyl-4(3
H
)-quinazolinone
(3j)
Yield 0.43 g (82%); colorless crystals;
mp 137-138 ˚C.
IR (KBr): 1668
(C=O), 1597, 1552, 1465, 1388, 1358, 1320, 1240, 1137,
1072, 1022, 947, 895, 822, 775 cm-¹. ¹H
NMR (300.1 MHz, CDCl3): δ = 1.25-1.97 [m,
10 H, CH(CH
2)5], 4.76-4.84 [m,
1 H, CH(CH2)5],
7.60 (d, J = 8.8
Hz, 1 H, CH), 7.63 (dd, J = 2.1,
8.8 Hz, 1 H, CH), 8.11 (d, J = 2.1
Hz, 1 H, CH), 8.26 (s, 1 H, CH). ¹³C
NMR (75.5 MHz, CDCl3): δ = 25.22,
25.28, and 32.56 (3 × CH2), 53.59 (NCH), 122.97 (C),
126.30 and 128.95 (2 × CH), 132.88 (C), 134.52 and 144.08
(2 × CH), 146.02 (C), 159.68 (C=O). MS (EI): m/z (%) = 264
(8) [M+ ³7Cl],
262 (22) [M+ ³5Cl],
228 (5), 205 (3), 181 (100), 163 (4), 147 (18), 136 (7), 124 (5),
110 (5), 97 (4), 82 (9), 67 (20), 55 (18), 41 (23). Anal. Calcd
for C14H15ClN2O (262.74): C, 64.00;
H, 5.75; N, 10.66. Found: C, 63.9; H, 5.7; N, 10.6.
6-Chloro-3-(1,1,3,3-tetramethylbutyl)-4(3
H
)-quinazolinone
(3l)
Yield 0.44 g (76%); colorless crystals;
mp 118-119 ˚C.
IR (KBr): 1662
(C=O), 1592, 1560, 1467, 1362, 1324, 1285, 1219, 1128,
1075, 918, 835, 805, 754, 712 cm-¹. ¹H
NMR (500.1 MHz, CDCl3): δ = 0.81 [s,
9 H, C(CH3)3], 1.75 [s,
6 H, C(CH3)2], 2.22 (s, 2 H, CH2),
7.56 (d, J = 8.9
Hz, 1 H, CH), 7.60 (dd, J = 2.2,
8.9 Hz, 1 H, CH), 8.20 (d, J = 2.2
Hz, 1 H, CH), 8.26 (s, 1 H, CH). ¹³C
NMR (125.8 MHz, CDCl3): δ = 30.00 [C(CH3)2],
31.24 [C(CH3)3],
31.93 [C(CH3)3], 48.88
(CH2), 64.76 [C(CH3)2],
124.13 (C), 126.23 and 128.55 (2 × CH), 132.66 (C), 134.34
and 144.84 (2 × CH), 145.85 (C), 161.41 (C=O).
MS (EI): m/z (%) = 294
(1) [M+ ³7Cl],
292 (3) [M+ ³5Cl],
235 (8), 180 (100), 163 (9), 153 (8), 138 (7), 124 (6), 112 (26),
97 (68), 69 (10), 57 (54), 41 (31). Anal. Calcd for C16H21ClN2O
(292.81): C, 65.63; H, 7.23; N, 9.57. Found: C, 65.7; H, 7.4; N,
9.4.